[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.41.181. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
March 1996

Multimodality Treatment of Hepatocellular Carcinoma in a Hepatobiliary Specialty Center

Author Affiliations

From the Divisions of Hepatobiliary Surgery and Liver Transplantation (Drs Marcos-Alvarez, Jenkins, Washburn, Lewis, and Clouse), Oncology (Dr Stuart), Hepatology (Dr Gordon), and Radiology (Drs Kane and Clouse), Deaconess Hospital, Harvard Medical School, Boston, Mass.

Arch Surg. 1996;131(3):292-298. doi:10.1001/archsurg.1996.01430150070014
Abstract

Objectives:  To review the experience on the treatment of hepatocellular carcinoma by a single multimodality team during a 6-year period, including all patients who were referred for possible surgical intervention, to evaluate prognostic factors at presentation, and to determine the results of the different modalities of treatment that were used.

Design:  Retrospective study of 154 patients who were referred to our Hepatobiliary Surgery Unit with the diagnosis of hepatocellular carcinoma from January 1988 through August 1995.

Setting:  Tertiary care center.

Results:  Methods of treatment included surgical resection (n=49), transplantation (n=22), hepatic artery chemoembolization (n=30), systemic chemotherapy (n=25), and no treatment (n=22). Predictive prognostic factors included coexisting cirrhosis, symptoms at presentation, and abnormal liver function test results. Unfavorable tumor characteristics were size (diameter, >5 cm) and multicentricity. For patients who underwent surgical exploration, advanced staging according to the manual of the American Joint Committee on Cancer, vascular invasion, and a margin of less than 1 cm in the group of patients who underwent resection impacted negatively on the prognosis. The median survival (42.4 months) for the group of patients who underwent resection was significantly higher than that for the groups of patients who did not undergo resection. Chemoembolization was associated with significantly better survival results than was systemic chemotherapy.

Conclusions:  Hepatic resection offers the best chance at cure for patients with hepatocellular carcinoma. The high association between hepatocellular carcinoma and cirrhotic liver disease makes surgical resection, even in favorable tumor types, a difficult task based on low hepatic reserve. Candidates with adequate hepatic reserve whose tumors are considered unresectable can be considered for chemoembolization. Liver transplantation should be reserved for selected patients with cirrhotic liver disease who have tumors (diameter, <5 cm) in the context of neoadjuvant protocols.(Arch Surg. 1996;131:292-298)

References
1.
DiBisceglie AM, Rutstgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT.  Hepatocellular carcinoma . Ann Intern Med . 1988;108:390-401.Article
2.
Scudamore CH, Ragaz J, Kluftinger AM, Owen DA.  Hepatocellular carcinoma: a comparison of Oriental and Caucasian patients . Am J Surg . 1988;155:659-662.Article
3.
Smalley SR, Moertel CG, Hilton JF, et al.  Hepatoma in the noncirrhotic liver . Cancer . 1988;62:1414-1423.Article
4.
Trevisiani F, D'lntimo PE, Caraceni P, et al.  Etiologic factors and clinical presentation of hepatocellular carcinoma . Cancer . 1995;75:2220-2232.Article
5.
Vauthey JN, Klimstra D, Franceschi D, et al.  Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma . Am J Surg . 1994; 169:28-34.Article
6.
Schwartz ME, Sung M, Mor E, Fisher A, et al.  A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis . JAm Coll Surg . 1995;180: 596-603.
7.
Nagorney DM, van Heerden JA, Ilstrup DM, Adson MA.  Primary hepatic malignancy: surgical managment and determinants of survival . Surgery . 1989; 106:740-749.
8.
Ringe B, Pichlmayr R, Wittekind C, Tusch G.  Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients . World J Surg . 1991;15:270-285.Article
9.
Iwatsuki S, TE Starzl.  Personal experience with 411 hepatic resections . Ann Surg . 1988;208:421-434.Article
10.
Mondazzi L, Bottelli R, Brambilla G, et al.  Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors . Hepatology . 1994;19:1115-1123.Article
11.
Kanematsu T, Furuta T, Takenaka K, et al.  A 5-year experience of lipiodolization: selective regional chemotheraphy for 200 patients with hepatocellular carcinoma . Hepatology . 1989;10:98-102.Article
12.
Stuart K, Stokes K, Jenkins RL, Trey C, Clouse M.  Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization . Cancer . 1993;72:3202-3209.Article
13.
Schwartz ME.  Primary hepatocellular carcinoma: transplant versus resection . Semin Liver Dis . 1994;14:135-139.Article
14.
Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A.  Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients . Ann Surg . 1993;218:145-151.Article
15.
Carr BI, Selby R, Madariaga J, Iwatsuki S, Starzl TE.  Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma . Transplant Proc . 1993;25:1128-1129.
16.
Haug CE, Jenkins RL, Rohrer RJ, et al.  Liver transplantation for primary hepatic cancer . Transplantation . 1992;53:376-382.Article
17.
Van Thiel DH, Carr B, Iwatsuki S, Selby RR, Fung JJ, Starzl TE.  The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991 . J Surg Oncol Suppl . 1993;3:78-82.Article
18.
American Joint Committee on Cancer. Manual for Staging of Cancer . 4th ed. Philadelphia, Pa: JB Lippincott; 1992:89-91.
19.
Kaplan EL, Meier P.  Nonparametric estimation from incomplete observations . J Am Stat Assoc . 1958;53:457-481.Article
20.
Kane RA, Hughes LA, Cua EJ, Steele GD, Jenkins RL, Cady B.  The impact of intraoperative ultrasonography on surgery for liver neoplasms . J Ultrasound Med . 1994;13:1-6.
21.
Nagorney DM, Adson MA, Weiland LH, Knight CD Jr, Smalley SR, Zinsmeister AR.  Fibrolamellar hepatoma . Am J Surg . 1985;149:113-119.Article
22.
Ringe B, Wittekind C, Weimann A, Tusch G, Pichlmayr R.  Results of hepatic resection and transplantation for fibrolamellar carcinoma . Surg Gynecol Obstet . 1992;175:299-305.
23.
Iwatsuki S, Starzl TE, Sheahan DG, et al.  Hepatic resection versus transplantation for hepatocellular carcinoma . Ann Surg . 1991;214:221-228.Article
24.
Farmer DG, Rosove MH, Shaked A, Busuttil RW.  Current treatment modalities for hepatocellular carcinoma . Ann Surg . 1994;219:236-247.Article
25.
Ravikumar TS, Onik G, Kane R, et al.  Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma . Arch Surg . 1987:122: 403-409.Article
26.
O'Connell MJ, Hahn RG, Rubin J, Moertel CG,  Chemotherapy of malignant hepatomas with sequential intraarterial doxorubicin and systemic 5-fluorouracil and semustine . Cancer . 1988;62:1041-1043.Article
27.
Bismuth H, Morino M, Sherlock D, et al.  Primary treatment of hepatocellular carcinoma by arterial chemoembolization . Am J Surg . 1992;163:387-394.Article
28.
Trinchet JC, Rached AA, Beaugrand M, Mathieu D, Chevret S, Chastang C.  A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma . N Engl J Med . 1995;332:1256-1261.Article
29.
Livraghi T, Bolondi L, Lazzaroni S, et al.  Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients . Cancer . 1992;69:925-929.Article
30.
Yokoyama I, Sheahan DG, Carr B, et al.  Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma . Transplant Proc . 1991;23:2194-2196.
31.
Stone MJ, Klintmalm GBG, Polter D, et al.  Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients . Gastroenterology . 1993;104:196-202.
32.
Venook AP, Ferrell LD, Roberts JP, et al.  Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization . Liver Transplant Surg . 1995;1:242-248.Article
33.
Romani F, Belli LS, Rondinara GF, et al.  The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver . J Am Coll Surg . 1994;178:379-384.
34.
Spreafico C, Marchiano A, Regalia E, et al.  Chemoebolization of hepatocellular carcinoma in patients who undergo liver transplantation . Radiology . 1994;192: 687-690.Article
35.
Klintmalm G, Stone M.  Liver transplantation for malignancy . Transplant Rev . 1990;4:52-58.Article
36.
Moreno-Gonzalez E, Gomez R, Garcia I, et al.  Liver transplantation in malignant primary hepatic neoplasms . Am J Surg . 1992;163:395-400.Article
37.
Penn I.  Hepatic transplantation for primary and metastatic cancers of the liver . Surgery . 1991;110:726-735.
×